Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by James Chesebro
Potent Arterial Antithrombotic Effect of Direct Factor-Xa Inhibition With ZK-807834 Administered to Coronary Artery Disease Patients
Thrombosis and Haemostasis
Hematology
Related publications
Antithrombotic Efficacy of Recombinant Tick Anticoagulant Peptide. A Potent Inhibitor of Coagulation Factor Xa in a Primate Model of Arterial Thrombosis
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Relationship of Coronary Collateral Development With Mean Arterial Pressure in Patients With Stable Coronary Artery Disease
Experimental Biomedical Research
Antithrombotic Therapy After Coronary Artery Stenting in Patients With Atrial Fibrillation
Circulation: Cardiovascular Interventions
Cardiovascular Medicine
Cardiology
Arterial Stiffness and Coronary Artery Disease
Journal of Cardiology & Cardiovascular Therapy
Plasma Insulin Response to Glucose as a Coronary Artery Disease Risk Factor in the Normolipidemic Patients With Angiographically Defined Coronary Artery Disease
The Journal of Japan Atherosclerosis Society
Specific Features of Target Organ Damage in Patients With Arterial Hypertension and Coronary Artery Disease
Role of Inflammatory Markers in Patients With Coronary Artery Ectasia Versus Patients With Obstructive Coronary Artery Disease
Cardiology Research and Cardiovascular Medicine
Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa Inhibitors
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Antithrombotic Drug and Its Clinical Indication. Factor Xa Inhibitor. Oral Xa Inhibitor (DX-9065a).
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology